【24h】

Study of the photolytic and photocatalytic transformation of amiloride in water.

机译:阿米洛利在水中的光催化和光催化转化研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The diffusion of drug residues in wastewaters and surface waters as rivers and streams may constitute a problem for the environment, with consequences on the ecosystem and also on the human health. This paper deals with the study of the photo-induced transformation of amiloride, an orally administered diuretic agent, under simulated solar light. Direct photolysis and photocatalyzed degradation processes, using titanium dioxide as a photocatalyst, were investigated. The study involved the monitoring of the drug decomposition, the identification of intermediate compounds of the decomposition, the assessment of mineralization, as well as the evaluation of the toxicity associated to the degradation products. Amiloride underwent complete degradation within 30min of irradiation (heterogeneous photocatalysis) or 4h (homogeneous photolysis). HPLC coupled to HRMS, via ESI interface, demonstrated to be a powerful tool to identify and measure degradation products of the studied drug. By considering the photocatalytic process, the identified intermediates are formed through: (1) dechlorination and hydroxylation of the heteroaromatic ring; (2) the detachment of the guanidinic moiety; (3) cleavage of the heteroaromatic ring. The drug photomineralization was a rather slow process and after 4h of irradiation 25% of the total organic carbon (TOC) was still present. Chlorine was stoichiometrically released as chloride ions within the considered irradiation times (4h), while nitrogen was only partially converted into ammonium ions. This was due to the formation of guanidine, known to be hardly mineralized photocatalytically, and some other small molecules still containing the nitrogen. Acute toxicity, measured with a Vibrio fischery assay, showed that amiloride transformation proceeded through the formation of toxic compounds.
机译:废水和地表水(如河流和溪流)中药物残留的扩散可能构成环境问题,对生态系统和人类健康造成影响。本文研究在模拟太阳光下口服施用的利尿剂阿米洛利的光诱导转化研究。研究了使用二氧化钛作为光催化剂的直接光解和光催化降解过程。该研究涉及药物分解的监测,分解的中间化合物的鉴定,矿化的评估以及与降解产物相关的毒性的评估。阿米洛利在辐照30分钟(非均相光催化)或4小时(均质光解)后经历了完全降解。 HPLC通过ESI接口与HRMS偶联,被证明是鉴定和测量所研究药物降解产物的强大工具。通过考虑光催化过程,通过以下方式形成了鉴定出的中间体:(1)杂芳环的脱氯和羟基化; (2)胍基部分的脱离; (3)杂芳环的裂解。药物光矿化是一个相当缓慢的过程,照射4小时后,仍然存在25%的总有机碳(TOC)。在所考虑的辐照时间内(4小时),氯以化学计量的形式作为氯离子释放,而氮仅部分转化为铵离子。这是由于胍的形成,众所周知该胍很难被光催化矿化,还有一些其他的小分子仍然含有氮。用弧菌弧菌测定法测定的急性毒性表明,阿米洛利的转化过程通过有毒化合物的形成而进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号